Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

NCT02134457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity (ROP)

Interventions

BIOLOGICAL: ranibizumab

Sponsor

University Hospital Freiburg